Prometheus Biosciences
RXDX
$199.92
Share price
0.00%
Change (1 day)
360.96%
Change (1 year)
Categories
Prometheus Biosciences (RXDX) - Net assets
Net assets on the balance sheet as of March 2023 : $0.69 B
According to Prometheus Biosciences's latest financial reports the company has $0.69 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Prometheus Biosciences - Net assets on balance sheet (from 2020 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.67 B | 187.46% |
| 2021-12-31 | $0.23 B | -341.08% |
| 2020-12-31 | $-97.55 M | 163.85% |
| 2019-12-31 | $-36.97 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Akebia Therapeutics AKBA | -$30.59 M | -104.38% | 🇺🇸 USA |
 Agenus
AGEN | -$0.15 B | -121.27% | 🇺🇸 USA |